Stem Cell Sentinel: Advanced Cell Technology Announces Critical Advancements in its RPE Program for the Treatment of Macular Degeneration and Other Retinal Degenerative D

Wednesday, June 20, 2007

Advanced Cell Technology Announces Critical Advancements in its RPE Program for the Treatment of Macular Degeneration and Other Retinal Degenerative D

Source: Advanced Cell Technology, Inc.
Posted: June 20, 2007 07:30 AM

Summary:

Advanced Cell Technology, Inc. today announced major advancements in the process of bringing its Retinal Pigment Epithelial (RPE) program into the clinic to treat various retinal degenerative diseases, including Age-Related Macular Degeneration (AMD).